An illustration with a colorful blue-red gradient has curving shapes representing the flow of time with icons representing cells, DNA, molecules, a syringe, etc.

Why Medical Advancements at Penn Power FDA Approved Treatments

Since 2017, the FDA has approved more than two dozen new therapies with roots at Penn Medicine — almost half of which are first-in-class for their indications. Becoming a hub for drug research and development took a lot more than luck.

The Pennovation Center, a wide brick building with angular glass shapes jutting from one end and the word “Pennovation” in large letters above the roofline.

The Path from Innovation to Implementation

Penn’s infrastructure in both supporting clinical research and forging commercial partnerships smooths the way from ideas to FDA-approved therapies.

Sunil Singhal, MD, examines lung tissue during a surgical procedure using a glowing tumor agent, while a colleague observes.

Why New Cancer Treatment Discoveries are Proliferating

There are fewer cancer deaths and more cancer therapies than ever, in part because scientists now design drugs to attack cancer based on its biology.

Curving shapes on a red/blue gradient background with icons indicating drugs, populations, and outreach.

Putting Biomedical Research Advances Within Reach

While driving biomedical innovation and new therapies, Penn pushes for equity to make vaccines and treatments available and accessible to more people.

Share This Page: